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bcl-2 and bax immunoreactivity in placentas from  
pregnancies complicated with intrauterine growth 
restriction and hypertension
Abstract
Because placental apoptosis associated protein imbalance is thought to 
contribute to the pathogenesis of intrauterine growth restriction (IUGR) and 
preeclampsia (PE), morphological features and expression of Bcl-2 and Bax 
were studied on samples from 10 human placentas from pregnancies com-
plicated with IUGR and PE and 10 placentas from uncomplicated term 
pregnancies.
In 9/10 placentas from the IUGR/PE group, the findings were consistent 
with hypoxic damage and in 1/10 placentas chronic villitis was found. In 
both groups Bax showed strong diffuse expression (3+) in amnionic epithe-
lium, blood vessel wall and endothelium in the chorionic plate and placen-
tal villi and the villous stroma in all placentas. The extravillous trophoblast 
(EVT) in the basal decidua showed 3+ Bax expression in 8/10 placentas 
and 2+ expression in 2/10 placentas in both groups. In the IUGR/PE group 
the Bax expression in both cyto (CT) and syncytiotrophoblast (ST), was 3+ 
in 8/10 placentas, and 2+ in 2/10 placentas. In the control group Bax expres-
sion was 3+ in both CT and ST in all 10 placentas. The 3+ Bcl-2 expression 
in both groups was found only in CT and ST. The syncytial knots in both 
groups showed 3+ positivity for Bax and Bcl-2. These findings do not confirm 
other authors’ findings about the increased expression of proapoptotic factors 
in the third trimester placentas with IUGR/PE, and the conclusion is that 
for the pathogenesis of IUGR and PE, the attention should be shifted to 
inappropriate apoptosis during the process of implantation.
INTRoduCTIoN
For the appropriate placentation and development of the placenta the extravillous trophoblast derived from the villi that anchor the devel-
oping blastocyst to the underlying decidua plays the most important 
role. It is the conversion of spiral arterioles into the uteroplacental blood 
vessels, resulting in the development of a high flow, low resistance vessels 
able to perfuse the intervillous space. At the surface of the placental 
villi, the syncytium is formed from underlying mitotically active mono-
nucleated cytotrophoblasts that differentiate and undergo fusion. The 
anatomical integrity of the syncytiotrophoblast is critical, as a variety of 
receptors and enzymes are strategically positioned on the maternal blood 
facing membrane and regulate maternal–fetal exchange (1). The villous Received September 18, 2013.
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trophoblast bilayer is delimited from the villous stroma 
which contains branching fetal blood vessels in a connec-
tive tissue matrix by a basement membrane. Placental 
function is critical at all stages of pregnancy, but nutrient 
transport demands on villous trophoblasts are highest as 
the fetus triples in weight during the third trimester of 
gestation (2). In preeclamsia (PE) a characteristic change 
of the spiral arteries, firstly described and named „acute 
atherosis“ can be seen in the basal decidua layer, as well 
as in the free placental membranes (3). Acute atherosis 
develops only in the spiral arteries that have not under-
gone physiologic changes, and the reason for this incom-
plete change still remains a mystery. Some authors have 
found a reduction in the extent of trophoblast invasion in 
severe preeclampsia, both in the spiral arteries and the 
myometrium (4). Poor trophoblast invasion and remodel-
ing of uterine spiral arteries have been suggested to lead 
to hypoperfusion, hypoxia, reperfusion injury, oxidative 
stress and signs of villous tree maldevelopment in the sec-
ond half of the pregnancy. Hypoxic environment in cases 
of impaired uteroplacental blood flow, causes necrosis of 
superficial, syncytiotrophoblastic layer with subsequent 
discontinuities. In normal circumstances, within the vil-
lous trophoblast, proliferation is restricted to the cytotro-
phoblasts, and apoptosis is almost exclusively localised to 
the syncyciotrophoblast (5). Bax, one of the proapoptotic 
members of the Bcl-2 family, is present in the villous tro-
phoblast in the first and third trimester. In the first tri-
mester, it is localized to the cytoplasm of the cytotropho-
blast, but in the third trimester it is expressed in the 
syncytiotrophoblast (6-8). The levels of apoptosis within 
tertiary villi increase with gestation, and are the greatest 
over 40 weeks of gestation (9). Insults that result in villous 
trophoblast injury may not be accompanied by a compen-
satory increase in cytotrophoblast proliferation and dif-
ferentiation (10, 11). Because of the extreme importance 
of apoptosis regulation, cultured trophoblasts exposed to 
hypoxia show a marked upregulation of p53 activity, en-
hanced expression of the pro-apoptotic Mtd-1 and de-
creased expression of the anti-apoptotic Bcl-2, all of which 
promote apoptosis (8, 12, 13). In contrast to hypoxia 
alone, hypoxia-reoxygenation results in more marked 
apoptosis regulated by other proteins such as the increased 
expression of the pro-apoptotic Bax and Bak (13-15). Ex-
pression of Bax is often associated with areas of tropho-
blast damage, or degeneration, such as fibrinoid deposits 
and syncitial knots (16, 17).
With all the data from the literature, we hypothesized 
that the expression of proapoptotic Bax protein will be 
enhanced in the tissue of placentas from the pregnancies 
complicated with PE and intrauterine growth restriction 
(IUGR), in comparison to the placentas from uncom pli-
cated term pregnancies. We also expected the expression 
of anti-apoptotic Bcl-2 protein to be strong in the areas 
of villous trophoblast damage, and in the areas of fibri-
noid deposition. This study is a pilot study of a larger 
study with the same hypotheses and aim which was to 
assess the expression of Bax and Bcl-2 proteins in diffe-
rent compartments of the placentas from the pregnan-
cies complicated with IUGR and PE, and to comapare 
the results with the expression of Bax and Bcl-2 in the 
corresponding compartments of the placentas from un-
complicated term pregnancies.
mATERIAlS ANd mEThodS
The material consisted od 10 samples of human pla-
cental tissue from the pregnancies complicated with 
IUGR and PE confirmed by serial clinical follow up. 
The control group consisted of 10 samples of human 
placental tissue from the uncomplicated term pregnan-
cies. The tissue in both groups was retrieved from the ar-
chive of the Clinical Department of Pathology „Ljudevit 
Jurak“, Clinical Hospital Center „Sestre Milosrdnice“ in 
Zagreb, where they were collected during the scientific 
project of the Ministry of science, education and sport of 
the Republic of Croatia, No. 108-1081870-1940. The 
samples contained full thickness of the placenta, from 
the chorionic plate membranes to the basal decidua, 
that were taken from the unfixed placental tissue dur-
ing routine pathological examination. The samples were 
routinely fixed in formalin and embedded in paraffin. 
Three sections of every sample were cut at 5 µm; one 
was stained routinely with hematoxylin-eosin (H-E) and 
examined by light microscopy to assess the morphology; 
the other two were analyzed after immunohistochemi-
cal staining for Bax (polyclonal rabbit anti-human, Code 
A3533, Dako Denmark) and Bcl-2 (monoclonal mouse 
anti-human, Clone 124, Code M0887, Dako, Den-
mark), respectively. For immunohistochemical analy-
sis the 5 µm thick sections of the placental tissue were 
mounted on a silanized slide, and left to dry for 24 h. 
The section were than deparaffinized in xylene, rehy-
drated through a graded series of alcohol and washed 
in phosphate buffered saline (PBS). PBS was used for 
all subsequent washes and for antiserum dilution. Tissue 
sections were treated with Catalyzed Signal Amplifica-
tion (CSA) System II for use with mouse primary anti-
bodies (Code K1497, Dako, Denmark). The CSA Sys-
tem II was adapted for the detection of rabbit polyclonal 
antibodies by replacing the anti mouse link provided in 
the kit with the CSA II Rabbit Link (Code 1501, Dako, 
Denmark). Immunohistochemical staining intensity 
was evaluated semiquantitatively as: negative (-), weakly 
positive (1+) if positive in solitary cells, up to 50% of 
cells; moderately positive (2+) if strongly positive in up 
to 50% of cells, moderately positive in > 50% of cells 
and strongly positive (3+) if strongly positive in > 50% 
of cells. The immunoreactivity was assessed in different 
parts of the placenta: extravillous trophoblast (EVT) 
in the basal decidua, villous cytotrophoblast (CT) and 
syncitiotrophoblast (ST), the villous stromal cells, the 
blood vessels of the chorionic plate and in the amnionic 
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epithelium of the chorionic plate. For the analysis of the 
results, descriptive methods were used.
RESulTS
The mean gestational age of women in group with 
IUGR/PE was 36 weeks (range 31 – 39 weeks), and in 
the control group it was 39 weeks (range 37 – 40 weeks). 
The mean placental weight in the group with IUGR/
PE was 330 g (range 250 – 380 g), and in the control 
group 438 g (range 390 – 520 g). Because of the fact that 
pregnancies complicated with PE and IUGR frequently 
terminate earlier, either spontaneously, or because of the 
threatening asphyxia of the fetus, there was no point in 
calculating statistical significance of the difference.
Grossly, one placenta in the control group was suc-
cen turiate, but on microscopic examination showed 
normally developed, term villi. On light microscopy 
histopathological examination of H-E stained placental 
tissue, fetal membranes and the umbilical cord showed 
normal morphology in all 10 placentas from IUGR/PE 
group as well as in the control group. Out of 10 placenta 
in the IUGR/PE group, none showed completely normal 
histological features. In 9/10 placentas the findings were 
consistent with hypoxic damage, while in 1/10 placentas 
a diffuse chronic villitis of unknown etiology (VUE) was 
found. In the control group of placentas, 1/10 showed a 
solitary, peripherally localized chronic infarct. The histo-
pathological findings of the placental tissue stained with 
H-E are shown in Table 1.
Immunoreactivity for Bax in both, group with IUGR/
PE and the control group showed the same pattern in 
all 10 placentas in each group: strong diffuse expression 
(3+) in amnionic epithelium (Figure 1) blood vessel wall 
and endothelium in the chorionic plate and the placen-
tal villi (Figure 2), and the villous stroma. In the EVT 
in the basal decidua strong expression (3+) was found 
in 8/10 placentas in both groups, while the expression 
was graded as moderate (2+) in 2/10 placentas in both 
groups (Figure 3). The Bax expression was strong and di-
ffuse (3+) in both CT and ST in the IUGR/PE group in 
8/10 placentas, and moderate (2+) in 2/10 placentas in 
this group (Figure 4). In the control group Bax expressi-
on was strong and diffuse (3+) in both CT and ST in all 
10/10 placentas (Figure 5). The syncytial knots in both 
groups showed strong (3+) positivity for Bax (Figure 6). 
The results of Bax expression are summarized in Table 2.
The Bcl-2 expression in both groups was found only 
in CT and ST, and estimated as strong (3+) in both anal-
yzed groups (Figure 7). All other elements were negative 
for Bcl-2 (Table 3).
TAble 1
Histopathological findings of the placental 
tissue stained with H-E.
Group/findings IUGR/PE* Control
Multiple chronic  
infarcts (+s.k**) 4 0
Solitary chronic  
infarct (+s.k.**) 1 1
Chorangiosis 3 0
Loss of vasculosyncytial  
membranes 1 0
Chronic villitis 1 0
Normal findings 0 9
Total 10 10
*Placentas from pregnancies complicated with IUGR/PE ** Excessive 
quantity of syncytial knots
Figure 1. Strong diffuse (3+) immunoreactivity for Bax in the am-
nionic epithelium of the placenta in the group with IUGR/PE (left) 
and in the control group (right). (Bax x 200)
Figure 2. Strong diffuse (3+) immunoreactivity for Bax in the am-
nionic epithelium of the placenta in the group with IUGR/PE (left) 
and in the control group (right). (Bax x 200)
Figure 3. Immunoreactivity for Bax in the EVT of the placenta in 
the group with IUGR/PE (left) and in the control group (right). 
(Bax x 200)
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dISCuSSIoN
In PE and IUGR, the placenta is frequently small 
(weight under the 10th percentile for gestational age, 
feto-placental ratio innappropriate for gestational age), 
with gross findings of multiple infarcts, and (especially 
in PE) 3-5 times more frequent findings of retroplacen-
tal hematoma. Histological findings may be very diffe-
rent, but mostly point out towards the inappropriate 
uteroplacental blood flow, such as the thickened cyto-
trophoblastic layer, very numerous syncitial knots and 
chorangiosis (18). Due to the development of a high 
pressure placental blood supply, the developing villo-
us tree can be damaged, showing changes in placental 
structure (19, 20). In placentas from pregnancies com-
plicated by IUGR these sites of injury and repair are 
covered with fibrin containing deposits, that can be fo-
und in every placenta, but are observed with increased 
frequency in placentas with IUGR. The fibrin matrix 
serves as a scaffold for trophoblast to re-epithelialize the 
villous surface. Syncytial knots, that are also observed in 
much greater quantity in placentas with PE, are clusters 
of apoptotic syncytial nuclei that bulge from the surface 
into the intervillous space. The underlying cytotropho-
blast population provides a source for new syncytium 
during normal epithelial turnover and at sites of syn-
cytial re-epithelialization of fibrin on the surface of villi, 
resulting with thickened cytotrophoblastic layer seen on 
light microscopy (18).
Figure 4. Moderate immunoreactivity (2+) for Bax in the villous 
trophoblast in the placenta in the group with IUGR/PE was found 
in 2/10 placentas. (Bax x 400)
Figure 5. Strong diffuse immunoreactivity (3+) for Bax in the villous 
trophoblast in the placenta was found in 8/10 placentas in the group 
with IUGR/PE (left) and in 10/10 placentas in the control group 
(right). (Bax x 400)
Figure 7. Strong immunoreactivity (3+) for Bcl-2 in the villous tro-
phoblast in the placenta in the group with IUGR/PE (left) and in 
the control group (right). (Bax x 400).
Figure 6. Strong immunoreactivity for Bax in the syncitial knots in 
the placenta in the group with IUGR/PE (left) and in the control 
group (right). (Bax x 400)
TAble 2





EVT in the basal decidua 10
     3+ 8 8
     2+ 2 2
CT and ST
     3+ 8 10
     2+ 2
Villous stromal cells
     3+ 10 10
Blood vessels 
     3+ 10 10
Amnionic epithelium 
     3+ 10 10
TAble 3






EVT in the basal decidua 0 0
CT and ST
     3+ 10 10
Villous stromal cells 0 0
Blood vessels 0 0
Amnionic epithelium 0 0
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Programmed cell death by apoptosis and its associ-
ated regulatory mechanisms are intimately involved in 
placental homeostasis, growth and remodeling with the 
apoptotic rates that increase progressively during nor-
mal pregnancy as part of normal placental development 
(21). Previous studies showed that Bcl-2 was generally 
expressed at low levels during the entire gestational pe-
riod, while Bax was low during the first trimester and 
increased towards the end of gestation. In accordance 
with the change of ratio of these two molecules, the 
increase of apoptotic cells was observable in the third 
trimester (22). In their study of Bcl-2 and Bax expres-
sion in preterm, term and postterm placentas Daher 
et al. found the same pattern of immunostaining for 
Bcl-2 and Bax in all samples, but reactivity for Bax was 
higher in preterm and postterm placentas, whether the 
reactivity for Bcl-2 decreased in preterm placentas. This 
reactivity pattern resulted in the higher Bax/Bcl-2 ratio 
in both pre-term and post-term placental samples com-
pared with term placentas (23). All these data indicate 
that Bcl-2 and Bax are temporally regulated during pla-
cental development and that the different expression of 
the above mentioned genes is at least in part responsible 
for the delicate balance between cell proliferation and 
programmed cell death in the human placenta during 
pregnancy.
In the present study, the analysis od Bax showed 
strong or, in the minority of cases, moderate expression 
in CT, ST, EVT, stromal cells of the villi, and endothelial 
cells in both analyzed groups. These findings confirm the 
findings of Cobellis et al. (24).
Although many molecules are associated with the in-
duction and prevention of apoptosis in different models 
one of them is a proapoptotic factor Bax and the same 
authors also observed an increase of Bax expression in 
all placental compartments in preeclampsia and diabe-
tes, compared to term placentas from uncomplicated 
pregnancies (24). Several studies demonstrated that 
apoptosis increases in pregnancies complicated by some 
pathologies such as preeclampsia, fetal growth restriction 
and diabetes (21, 25-27). Other authors’ observations 
were similar, not only by means of immunohistochemi-
stry alone, but also with combined methods and TU-
NEL (terminal deoxyribonucleotidyltransferase-medi-
ated dUTP and-labelling) (16). The etiology of IUGR 
and PE is still unclear, however placental dysfunction is 
considered a common underlying cause in both condi-
tions. The role of apoptosis in the development of pla-
cental pathology of these conditions has yet to be expla-
ined. The theory that the placentas in these pregnancy 
disorders display altered cell kinetics is corroborated by 
the findings of an increase of Bax expression is observed 
in all the placental compartments, especially in preec-
lampsia (28). In both IUGR and PE, apoptosis may 
disrupt the cytotrophoblast turnover that is, especially 
in PE increased, commencing with increased prolifera-
tion of cytotrophoblast, that could produce increased 
end stages of apoptosis in the syncitioblast (25). Han et 
al. demonstrated that caspase-10 and death receptor 3 
(DR-3) were upregulated in placenta from preeclamptic 
patients, suggesting that placental apoptosis and altered 
gene expression in the trophoblast may influence the pa-
thogenesis of preeclampsia (27).
The results of this study did not confirm the above 
mentioned findings, because the expression of Bax was 
practically of the same intensity in the group of placen-
tas with IUGR/PE and the control group in all placental 
compartments. Perhaps the studied group was too small, 
perhaps the immunoreagents was not properly chosen 
and perhaps in this group there was just no difference. 
Although some authors found that the expression of Bax 
is often associated with fibrinoid deposits and syncitial 
knots, in this study no difference was found between 
the expression of Bax in fibrinoid deposits in the inves-
tigated placentas and the control group (16, 17). As to 
the expression of Bcl-2, many factors capable of regu-
lating apoptosis are present in the villous trophoblast, 
but it seems that their expression change with pregnancy 
progression. The syncitiotrophoblast is protected against 
unwanted apoptosis by expression of Bcl-2 (and some 
other anti-apoptotic factors). In this study, the expressi-
on of Bcl-2 was restricted to villous trophoblast, where 
it was found to be mostly strong, and in several cases (in 
the IUGR/PE group) moderate. It was also strong in the 
syncytial knots, in both analyzed groups, but the expre-
ssion of Bax was found to be strong in both analyzed 
groups as well.
Recently, it has been suggested that vascular remo-
deling that occurs during placentation may be indi rectly 
controlled by intravascular trophoblast that stimulates 
endothelial cells to secrete chemokines. These chemo-
kines attract decidual leukocytes, particularly uterine 
natural killer cells and macrophages, leading to vascular 
smooth muscle cell apoptosis (29). A suggested mecha-
nism for endothelial cell destruction is via the Fas/FasL 
system, which is present on endothelial and vascular 
smooth muscle cells of the uterine spiral arteries (30). In 
PE and IUGR, there may be a reduction in the number 
of trophoblast cells within the spiral arteries, which has 
been associated with increased apoptosis and a reduced 
luminal size (30, 31). Many authors have found signifi-
cant increases in placental apoptosis, which may be the 
underlying cause in the pathophysiology of preeclampsia 
and IUGR, but this was not confirmed in this study. The 
reason for this discrepancy cannot be found. However, 
there is a growing body of evidence that suggests that 
abnormal apoptosis has important effects at the very be-
ginning of the placental development, namely the physi-
ological conversion of spiral arteries to uteroplacental 
vessels. In our opinion, this is the real cause of IUGR 
and/or PE, and the attention has to be shifted from the 
analysis of apoptosis in the third trimester or term pla-
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centas to the apoptosis in the placental bed in cases of 
spontaneous early miscarriages, or missed abortions.
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